211At-OKT10-B10
/ Fred Hutchinson Cancer Center
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
February 16, 2024
Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=0 | Withdrawn | Sponsor: Fred Hutchinson Cancer Center | N=30 ➔ 0 | Recruiting ➔ Withdrawn
Enrollment change • Trial withdrawal • Bone Marrow Transplantation • Hematological Malignancies • Multiple Myeloma • Oncology • Transplantation • CD34
September 15, 2023
Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Fred Hutchinson Cancer Center | Withdrawn ➔ Recruiting | Trial completion date: Mar 2026 ➔ Sep 2027 | Trial primary completion date: Mar 2024 ➔ Oct 2025
Enrollment open • Trial completion date • Trial primary completion date • Bone Marrow Transplantation • Hematological Malignancies • Multiple Myeloma • Oncology • Transplantation • CD34
September 01, 2023
Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=0 | Withdrawn | Sponsor: Fred Hutchinson Cancer Center | N=30 ➔ 0 | Recruiting ➔ Withdrawn
Enrollment change • Trial withdrawal • Bone Marrow Transplantation • Hematological Malignancies • Multiple Myeloma • Oncology • Transplantation • CD34
July 28, 2022
Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Fred Hutchinson Cancer Center | Not yet recruiting ➔ Recruiting
Enrollment open • Bone Marrow Transplantation • Hematological Malignancies • Multiple Myeloma • Oncology • Transplantation • CD34
1 to 4
Of
4
Go to page
1